ASLAN Pharmaceuticals Ltd (ASLN)
0.4471
-0.01
(-2.78%)
USD |
NASDAQ |
May 03, 16:00
0.4539
+0.01
(+1.52%)
After-Hours: 20:00
ASLAN Pharmaceuticals Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | -9.654M |
| September 30, 2018 | -10.52M |
| June 30, 2018 | -9.236M |
| March 31, 2018 | -10.06M |
| December 31, 2017 | -10.24M |
| September 30, 2017 | -8.821M |
| Date | Value |
|---|---|
| June 30, 2017 | -8.973M |
| March 31, 2017 | -6.077M |
| December 31, 2016 | -5.277M |
| September 30, 2016 | 6.333M |
| June 30, 2016 | -2.810M |
| March 31, 2016 | -4.035M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 54.44M |
| Concord Medical Services Holdings Ltd | -- |
| WAVE Life Sciences Ltd | -33.24M |
| Zai Lab Ltd | -14.92M |
| CytoMed Therapeutics Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -850.9% |